Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 30, 2009

View Archived Issues

Novel Rho kinase inhibitors in early development at Abbott

Merck KGaA claims sodium-glucose transporter inhibitors as antidiabetics

Johns Hopkins University describes novel protease inhibitors for treating HCV infection

HDAC1 inhibitors presented by Novartis for the treatment of cancer

Novel Plk-1 inhibitors identified by 4SC for the treatment of cancer

Abbott claims novel GlyT-1 inhibitors as anxiolytics

UAB, Southern Research and Jubilant Organosys enter joint venture

Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors

Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects

ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo

GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS

Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting

Novartis ends asthma and allergy research agreement with Idera Pharmaceuticals

Multaq approved in E.U. for treatment of atrial fibrillation

ATIR enters advanced clinical testing for graft-versus-host disease

Studies clarify genetic predisposition for Chlamydia trachomatis infections / News in Context

Complete response letter issued for extended indication of telavancin in the U.S.

European Commission approves Micardis for cardiovascular protection indication

EMEA validates ChemGenex's MAA for omacetaxine mepesuccinate

SciClone completes patient enrollment for SCV-07 phase II trial in oral mucositis

Roswell Park physician receives grant to investigate HDAC inhibitors in RCC

Photocure's NDA for Hexvix to be reviewed by FDA in December 2009

Approval of Pharmaxis' Aridol recommended by FDA advisory committee

MDRNA and Vancouver Prostate Center to extend collaboration on bladder cancer project

Encouraging phase II data on K-201 in atopic eczema announced by Moberg Derma

GlaxoSmithKline withdraws U.S. supplemental NDA for Avodart

GlaxoSmithKline discloses promising clinical data on H1N1 vaccine Pandemrix

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...